Influence of Authorized Smokeless Tobacco Product Modified Risk Claims I: Consumer Product Demand

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

160 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-09-25

Study Completion Date

2026-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To explore consumer responses to the announcement and implementation of new modified risk claims for Copenhagen and General Snus (brands of smokeless tobacco (ST) products) using a series of complementary and innovative research activities and methods.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effects of FDA Authorized Smokeless Tobacco Claims Among US Adults Who Smoke Cigarettes

NCT06927700

Tobacco Product Beliefs and Use

COMPLETED NA

Human Laboratory Study of the Effects of Nicotine Product Claims on Appeal, Perceptions, and Use Behavior

NCT06192316

Behavior, Risk

RECRUITING NA

Novel Determinants and Measures of Smokeless Tobacco Use: Study 1

NCT01067586

Smokeless Tobacco Use Tobacco Dependence

COMPLETED

The Impact of Cigarillo Warnings on Purchasing

NCT05434013

Cigar Smoking

COMPLETED NA

Post-Market Surveillance of Tobacco Products

NCT04255459

Smoking, Tobacco Smoking Behaviors

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Primary Objectives:

To assess the influence of smokeless tobacco products' modified risk claims on:

1. Product demand (measured as willingness to pay in USD) using an experimental auction approach; and
2. Perceived risk of tobacco-associated diseases as assessed using questionnaire-based measures.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Smoking Behaviors

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A - no claim

Participants view smokeless tobacco ads with no claims

Group Type SHAM_COMPARATOR

Modified Risk - None

Intervention Type BEHAVIORAL

Participants view ads with no modified risk claim

Group B - Modified Risk Tobacco Product Claim

Participants view ads with a modified risk claim

Group Type ACTIVE_COMPARATOR

Modified Risk Claim

Intervention Type BEHAVIORAL

Participants view ads with a modified risk claim

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Modified Risk - None

Participants view ads with no modified risk claim

Intervention Type BEHAVIORAL

Modified Risk Claim

Participants view ads with a modified risk claim

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Residing in one of the 8 counties of Western New York (Erie, Niagara, Cattaraugus, Chautauqua, Allegheny, Livingston, Genesee, Orleans, Wyoming).
* Smoke cigarettes every day, at least 5 cigarettes per day, for at least 1 year.
* Open to trying a non-combusted oral tobacco product.
* Have access to a device (ie: computer/tablet/smartphone) with internet capabilities to participate in an online survey study.
* Have the ability to read, write, and communicate in English.
* Participant must understand the investigational nature of this study and an Independent Ethics Committee/Institutional Review Board approved information sheet prior to receiving any study related procedure

Exclusion Criteria

* Plan to quit smoking in the next 30 days.
* Use of smokeless tobacco at least weekly in the last 6 months.
* Lifetime use (that is, ever used at any time prior to the study) of Copenhagen or General Snus.
* Unwilling or unable to follow protocol requirements.
* Pregnant or planning to become pregnant (by self report)

Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes